Search results for "Dication"

showing 10 items of 733 documents

HCV eradication: a duty of the State, an option for the individual

2020

In recent years, the debate on ethical issues related to hepatitis C virus therapies has been focused on the problem of drug prices and access to therapies. Nonetheless, the goal of hepatitis C virus eradication set by the World Health Organization in 2016 is raising new ethical issues, since governments are faced with a new challenge: reaching through screening, diagnosis and treatment a large amount of subjects with undiagnosed hepatitis C infection. National governments, especially high-income countries with a Welfare State, are compelled to provide access to therapies, but also to involve those who are still unaware of their disease status. Since people cannot be forced but should be gu…

medicine.medical_specialtyCost effectivenessmedia_common.quotation_subjectHepatitis C virusmedicine.disease_causeSettore MED/02 - Storia Della Medicina03 medical and health sciences0302 clinical medicineState (polity)Settore MED/43 - Medicina Legalemedicinehcv030212 general & internal medicineEthicIntensive care medicineDutyAutonomymedia_commonEradicationEthical issuesbusiness.industryWelfare stateHepatitis Cmedicine.diseaseCost-effectivenessbusinessAutonomy
researchProduct

Medication errors and risk areas in a critical care unit

2020

The aim of this study was to identify the main medication errors, their causality and the highest risk areas in critical care.A descriptive, longitudinal and retrospective study.We performed a systematic analysis of the prescription, transcription and administration records of 2,634 dose units of medications that were administered to a total of 87 critically ill patients during 2018.Final results have shown important medication errors and a high number of significant drug interactions; prescription phase had the highest mistake rate (71%) and cause of errors (68%); transcription stage had a more variable error typology. A significant correlation was observed between the presence of causes a…

medicine.medical_specialtyCritical CareCritical IllnessDose Unitslaw.invention03 medical and health sciences0302 clinical medicinelawIntervention (counseling)medicineHumansMedication Errors030212 general & internal medicineMedical prescriptionGeneral NursingRetrospective StudiesAdministering medications030504 nursingbusiness.industryRetrospective cohort studyPharmacoepidemiologyCausalityIntensive care unitIntensive Care UnitsEmergency medicine0305 other medical sciencebusinessJournal of Advanced Nursing
researchProduct

Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy :…

2019

Aim To compare clinical characteristics and outcomes in adults with type 1 diabetes aged ≥ 60 years using continuous subcutaneous insulin infusion (CSII) vs. insulin injection therapy. Further, to determine the percentage of older adults with type 1 diabetes using CSII. Research design and methods Retrospective study using data of the Diabetes Prospective Follow-up Registry (DPV). Including percentage CSII use from 2008 to 2018, and the characteristics of 9547 individuals extracted from the DPV in March 2019 (N = 1404 CSII; N = 8143 insulin injection therapy). Wilcoxon rank sum tests were used for continuous variables and chi-square tests for categorical variables to compare clinical charac…

medicine.medical_specialtyDiabetic ketoacidosisEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolism03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineDiabetes mellitus Type 1Internal MedicineMedicine030212 general & internal medicineddc:610ContraindicationDepression (differential diagnoses)AgedType 1 diabetesbusiness.industryInsulinCSIIDiabetes mellitus; TherapyDiabetes mellitus Typ 1Retrospective cohort studymedicine.diseaseInsulin infusion systems3. Good healthMicroalbuminuriaOlder peopleInsulinpumpebusinessAlter <60-90 Jahre>
researchProduct

Compounded preparations in dermatology – analysis of prescribing habits in everyday clinical practice in Germany

2020

Background Compounded preparations (CPs) are an indispensable addition to approved, commercially available drugs (CADs), especially for topical therapy. In Germany, about eight million CPs are prescribed within the statutory health insurance system each year, 50 % thereof by dermatologists. Methods We analyzed prescribing habits based on a questionnaire sent out to 186 office-based dermatologists and 1,491 pharmacies in the federal states of Rhineland-Palatinate and Saarland. The goal was to improve patient care by collecting and categorizing data in terms of prescription practice and associated challenges in interdisciplinary cooperation. Results Overall, 351 pharmacists (23.5 %) and 53 de…

medicine.medical_specialtyDrug CompoundingMEDLINEContext (language use)PharmacyDermatologyPharmacistsSkin Diseases030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineContinuing medical educationGermanySurveys and QuestionnairesHumansMedicinePractice Patterns Physicians'Medical prescriptionPharmaciesbusiness.industryCompounded preparationsTopical medicationClinical PracticeCross-Sectional StudiesFamily medicineDermatologic AgentsbusinessDermatologistsJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Diabetes mellitus secondary to Cushing's disease

2018

Associated with important comorbidities that significantly reduce patients’ overall wellbeing and life expectancy, Cushing’s disease (CD) is the most common cause of endogenous hypercortisolism. Glucocorticoid excess can lead to diabetes, and although its prevalence is probably underestimated, up to 50% of patients with CD have varying degrees of altered glucose metabolism. Fasting glycemia may nevertheless be normal in some patients in whom glucocorticoid excess leads primarily to higher postprandial glucose levels. An oral glucose tolerance test should thus be performed in all CD patients to identify glucose metabolism abnormalities. Since diabetes mellitus (DM) is a consequence of cortis…

medicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismDisease030204 cardiovascular system & hematologyCarbohydrate metabolismlcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineInsulin resistanceCortisol-lowering medication; Cushing's disease; Diabetes; Glucocorticoids; Insulin resistance; Endocrinology Diabetes and MetabolismEndocrinologyInternal medicineDiabetes mellitusmedicineGlucocorticoidslcsh:RC648-665business.industryDiabetesInsulin resistanceCushing's diseaseCushing’s diseasemedicine.diseaseDiabetes and MetabolismEndocrinologyPostprandialCortisol-lowering medicationCushing's diseasePituitary surgerybusinessGlucocorticoidmedicine.drug
researchProduct

Advantage of eradication therapy for Helicobacter pylori before kidney transplantation in uremic patients.

2007

ABSTRACT From January 1999 to February 2007, 61 end-stage renal disease (ESRD) candidates for kidney transplantation underwent an esophagogastroduodenoscopy (EGDS) to detect Helicobacter pylori (HP). We correlated treatment for HP before transplantation and upper digestive tract hemorrhagic complications and possible recurrence of peptic disease posttransplantation. The 32 (52.4%) HP-Positive cases were divided into 2 groups: (1) 17 patients who underwent treatment for the eradication of the infection with 40 mg/d omeprazole for 4 weeks, 500 mg claritromycin twice daily for 7 days, and 2 g/d amoxicillin for 7 days; and (2) 15 untreated patients. No significant differences were found in the …

medicine.medical_specialtyGastroenterologyHelicobacter InfectionsPostoperative ComplicationsInternal medicineeradicationPreoperative CareMedicineHumansStomach UlcerKidney transplantationOmeprazoleUremiaKidneytherapybiologymedicine.diagnostic_testHelicobacter pyloribusiness.industryEsophagogastroduodenoscopyAmoxicillinHelicobacter pylorimedicine.diseasebiology.organism_classificationKidney TransplantationSurgeryTransplantationmedicine.anatomical_structureDuodenal UlcerGastritisSurgerybusinessKidney diseasemedicine.drugtransplantationTransplantation proceedings
researchProduct

Cholecystectomy in high-risk patients: A comparison between open cholecystectomy and laparoscopic cholecystectomy

1998

SummaryLaparoscopic cholecystectomy offers many advantages, yet patients with a history of cardiopulmonary problems are at an increased risk because of the hemodynamic and respiratory effects of pneumoperitoneum. Between June 1990 and November 1997, a laparoscopic cholecystectomy was performed on 31 high risk patients [American Society of Anesthesiology (ASA) IV] and 40 conventional cholecystectomies were performed on patients with the same operative risk (ASA IV). In total, 15.5% (n = 11) of these patients experienced intraoperative cardiopulmonary complications, occurring with approximately the same frequency in both groups. General post-operative complications were seen in 28.2% (n=20) o…

medicine.medical_specialtyHigh risk patientsbusiness.industrymedicine.medical_treatmentGeneral surgeryHemodynamicsmedicine.diseaseSurgeryPneumoperitoneumAnesthesiologymedicineSurgeryCholecystectomybusinessComplicationLaparoscopic cholecystectomyContraindicationMinimally Invasive Therapy &amp; Allied Technologies
researchProduct

Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis

2016

A 46-year-old female Caucasian patient was referred to our unit with upper extremity claudication, dyspnoea [New York Heart Association (NYHA) Class III], and weight loss. On physical examination, ...

medicine.medical_specialtyHypertension PulmonaryAntibodieTakayasu arteritisImmunologyPhysical examinationClass iiiTakayasu ArteritiAntibodies Monoclonal HumanizedTocilizumab therapyNew york heart association03 medical and health sciences0302 clinical medicineAntibodies Monoclonal Humanized; Female; Humans; Hypertension Pulmonary; Middle Aged; Takayasu Arteritis; Immunology and Allergy; Rheumatology; Immunology; Medicine (all)RheumatologyWeight lossInternal medicineMonoclonalmedicineImmunology and AllergyHumanized030203 arthritis & rheumatologymedicine.diagnostic_testbusiness.industryMedicine (all)General MedicinePulmonaryMiddle Agedmedicine.diseasePulmonary hypertensionSettore MED/16 - ReumatologiaHypertensionCardiologyFemalemedicine.symptomClaudicationbusiness030217 neurology & neurosurgeryHuman
researchProduct

Anästhesiologisches Management bei der Versorgung von Mukoviszidose-Patienten1

2000

Objective: Improvements in the management of patients with cystic fibrosis (CF) result in increased life expectancy. Thus it is likely that anesthetists will see this patients with increasing frequency. This study describes our experiences in the anesthetic management of CF patients. Methods: We descriptively and retrospectively reviewed the records of all CF patients from 1981 until 1997 who underwent elective surgery in our department of ear, nose and throat and in whom general anesthesia was required. Results: 199 anesthetics in 53 patients were reviewed. Premedication with midazolam (0.4±0.07 mg/kg) were given orally in 163 of the 199 anesthetics (82%). In 45 anesthetics the induction w…

medicine.medical_specialtyInhalationbusiness.industryRespiratory diseaseGeneral MedicinePerioperativeCritical Care and Intensive Care Medicinemedicine.diseasePulmonary function testingSurgeryAnesthesiology and Pain Medicinemedicine.anatomical_structureAnesthesiaEmergency MedicinemedicineMidazolamPremedicationElective surgerybusinessNosemedicine.drugains · Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct

Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative

2019

Abstract Background Lithium is recommended as a first line treatment for bipolar disorders. However, only 30% of patients show an optimal outcome and variability in lithium response and tolerability is poorly understood. It remains difficult for clinicians to reliably predict which patients will benefit without recourse to a lengthy treatment trial. Greater precision in the early identification of individuals who are likely to respond to lithium is a significant unmet clinical need. Structure The H2020-funded Response to Lithium Network (R-LiNK; http://www.r-link.eu.com/) will undertake a prospective cohort study of over 300 individuals with bipolar-I-disorder who have agreed to commence a …

medicine.medical_specialtyLithium (medication)[SDV]Life Sciences [q-bio]Psychological interventionOmicsNeuroimagingReviewLithiumDigitallcsh:RC321-57103 medical and health sciences0302 clinical medicinemedicineProspective cohort studyIntensive care medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryPersonalizationbusiness.industrylcsh:QP351-495ResponseActigraphyPrecisionOmicsActigraphy3. Good health030227 psychiatryPsychiatry and Mental healthlcsh:Neurophysiology and neuropsychologyPhenotypeMoodTolerabilityBipolarBiomarker (medicine)business030217 neurology & neurosurgerymedicine.drugInternational Journal of Bipolar Disorders
researchProduct